[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"stage-1-hypertension\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:stage-1-hypertension":24},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":25,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":5},"100632585","observational-study-to-evaluate-the-efficacy-of-olmetec-tab-on-nocturnal-blood-pressure-control-in-patients-with-stage--hypertension-100632585",false,"NCT07515599","Observational Study to Evaluate the Efficacy of OLMETEC Tab on Nocturnal Blood Pressure Control in Patients With Stage Ⅰ Hypertension","A Prospective, Multi-Center, Observational Study to Evaluate the Efficacy of OLMETEC Tab. (or OLMETEC Plus Tab.) on Nocturnal Blood Pressure Control in Korean Patients With Stage Ⅰ Hypertension","Inclusion Criteria:\n\n* Adults aged ≥19 years\n* Patients diagnosed with stage 1 hypertension according to clinical guidelines\n* Patients who are newly prescribed Olmetec® or Olmetec Plus® in routine -clinical practice\n* Patients who are able to undergo ambulatory blood pressure monitoring (ABPM)\n* Patients who voluntarily agree to participate and provide written informed consent\n\nExclusion Criteria:\n\n* Patients with secondary hypertension\n* Patients with severe hypertension requiring immediate pharmacological i-ntervention\n* Patients with known hypersensitivity to olmesartan medoxomil, hydrochlorothiazide, or any component of the study drugs\n* Patients who are pregnant, planning to become pregnant, or breastfeeding\n* Patients with severe renal impairment or severe hepatic impairment\n* Patients who are unable to comply with study procedures, including ABPM\n* Patients who are deemed inappropriate for participation by the investigator","ALL","19 Years",{"count":19,"type":20},12000,"ESTIMATED","OBSERVATIONAL","This is a prospective, multicenter, observational study to evaluate the effectiveness of Olmetec® or Olmetec Plus® on nocturnal blood pressure control in Korean patients with stage 1 hypertension. Patients receiving Olmetec-based therapy in routine clinical practice will be followed to assess changes in ambulatory blood pressure, including nocturnal blood pressure and blood pressure variability.",[24],"Stage 1 Hypertension",[26],"hypertension","RECRUITING","2026-03-31",{"date":30,"type":31},"2026-04-07","ACTUAL",{"date":33,"type":31},"2025-09-17",{"date":35,"type":20},"2027-01-31",{"name":37,"class":38},"Daewoong Pharmaceutical Co. LTD.","INDUSTRY"]